Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Managing Distress in Malignant Brain Cancer - Phase IIc RCT

NCT06180460 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.

NCT NCT06180460
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06180460 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Managing Distress in Malignant Brain Cancer - Phase IIc RCT
Lead sponsor
Virginia Commonwealth University
Phase
Not applicable
Overall status
Completed
Start date
November 10, 2023
Completion date
September 30, 2025
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain cancer, brain metastases, brain tumor, metastatic breast cancer, metastatic colon cancer, metastatic kidney cancer, metastatic lung cancer, metastatic melanoma